This compound is a protected amino acid derivative used as an intermediate in peptide synthesis. It features a fluorenylmethoxycarbonyl (Fmoc) protecting group and an oxazolidine ring system, which are characteristic of building blocks employed in solid-phase peptide assembly.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 955048-92-7
Fmoc-Glu(OtBu)-Ser(Psi(Me,Me)pro)-OH
research compound
4-Oxazolidinecarboxylic acid, 3-[(2S)-3-(1,1-dimethylethoxy)-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-1-oxopropyl]-2,2-dimethyl-, (4S)-
pharmaceutical intermediate
Fmoc-Lys(Boc)-Ser(Psi(Me,Me)pro)-OH
pharmaceutical intermediate
FMOC-ASN(TRT)-SER(PSIME,MEPRO)-OH
research compound
(S)-2-[(tert-Butoxycarbonyl)amino]-3-(benzyloxycarbonylamino)propionic acid
pharmaceutical intermediate
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-methylbutanoic acid
pharmaceutical intermediate
N-Benzyloxycarbonyl-D-aspartic acid
pharmaceutical intermediate
Acetyl octapeptide-3
pharmaceutical intermediate
(4S)-3-[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-[(2-methylpropan-2-yl)oxy]-4-oxobutanoyl]-2,2-dimethyl-1,3-oxazolidine-4-carboxylic acid
AUPKCQXNRAZESL-GOTSBHOMSA-N
CC1(N([C@@H](CO1)C(=O)O)C(=O)[C@H](CC(=O)OC(C)(C)C)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24)C
—